Prognostic aspects of DCE-MRI in recurrent rectal cancer

European Radiology

Volumn 23, Issue 12, 2013, Pages 3336-3344

  Gollub, M J ^a   Cao, K ^b   Gultekin, D H ^a   Kuk, D ^a   Gonen, M ^a   Sohn, M ^a   Schwartz, L H ^c   Weiser, M R ^a   Temple, L K ^a   Nash, G M ^a   Guillem, J G ^a   Wang, M ^d   Garcia Aguilar, J ^a   Goodman, K ^a   Paty, P B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c NewYork Presbyterian Hospital   (United States)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Biomarker; DCE MRI; Rectal cancer; Recurrence; Resection margin

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CONTINUOUS INFUSION; DYNAMIC CONTRAST ENHANCEMENT MAGNETIC RESONANCE IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGIST; RECTUM CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84890554969     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2984-x     Document Type: Article

References (28)

1. Rodriguez-Bigas MA, Chang GJ, Skibber JM (2010) Multidisciplinary approach to recurrent/unresectable cancer: how to prepare for the resection. Surg Oncol Clin N Am 19:847-859
2. Moore HG, Shoup M, Riedel E et al (2004) Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 47:1599-1606
3. Goh V, Padhani AR, Rasheed S (2007) Functional imaging of colorectal cancer angiogenesis. Lancet Oncol 8:245-255
4. Kierkels RG, Backes WH, Janssen MHM et al (2010) Comparison between perfusion computed tomography and dynamic contrast enhanced magnetic resonance imaging in rectal cancer. Int J Radiat Oncol Biol Phys 77:400-408
5. De Lussanet QG, Backes WH, Griffen AW et al (2005) Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 13:1309-1315
6. Atkin G, Taylor NJ, Daley FM et al (2006) Dynamic contrast enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Br J Surg 93:992-1000
7. Kremser C, Trieb T, Rudisch A et al (2007) Dynamic T1 mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging 26:662-671
8. Sahani DV, Kalva SP, Hamberg LM et al (2005) Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 234:785-792
9. Dinter DJ, Horisberger K, Zechmann C et al (2009) Can dynamic MR imaging predict response in patients with rectal cancer undergoing Cetuximab-based neoadjuvant chemoradiation? Onkologie 32:86-93
10. De Vries A, Griebel J, Kremser C et al (2000) Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 217:385-391
11. DeVries AF, Griebel J, Kremser C et al (2001) Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 61:2513-2516
12. Habr-Gama A, Perez RO, Wynn G et al (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53:1692-1698
13. Capirci C, Valentini V, Cionini L et al (2008) Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 72:99-107
14. Rödel C, Martus P, Papadoupolos T et al (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23(8688-96):17
15. Kety SS (1951) The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3:1-41
16. Weinmann HJ, Laniado M, Mützel W (1984) Pharmacokinetics of Gd DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16:167-172
17. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17:357-367
18. Jarnagin WR, Schwartz LH, Gultekin DH et al (2009) Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 20:1589-1595
19. Lockhart AC, Rothenberg ML, Dupont J et al (2010) Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. J Clin Oncol 28:207-214
20. Henry LR, Sigurdson E, Ross EA, Lee JS, Watson JC, Cheng JD, Freedman GM, Konski A, Hoffman JP (2007) Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome. Ann Surg Oncol 14:2000-2009
21. Caricato M, Borzomati D, Ausania F, Valeri S, Rosignoli A, Coppola R (2006) Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 32:126-132
22. Hawnaur JM, Zhu XP, Hutchinson CE (1998) Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. Br J Radiol 71:1136-1142
23. Kanemitsu Y, Hirai T, Komor K, Kato T (2010) Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer. Dis Colon Rectum 53:779-789
24. Kusters M, Marinjen CAM, van de Velde CJH et al (2010) Pattern of local recurrence in rectal cancer: a study of the Dutch TME trial. Eur J Surg Oncol 36:470-476
25. Smith JD, Nash GM, Weiser MR, Temple LK, Guillem JG, Paty PB (2012) Multivisceral resections for rectal cancer. Br J Surg 99:1137-1143
26. Kusters M, Dresen RC, Martin H et al (2009) Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 75:1444-1449
27. Hahnloser D, Nelson H, Gunderson LL et al (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502-508
28. Georgiou PA, Tekkis PP, Brown G (2011) Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options. Cancer Imaging 11:S103-S111